Foley Hoag advised Thermo Fisher Scientific on the deal. Thermo Fisher Scientific (NYSE: TMO), a world leader in serving science, acquired Combinati Incorporated and its digital PCR...
You must be a Standard 1 Year member to access this content.
Norton Rose Fulbright and Foley Hoag represented Vineyard Wind on the deal. Latham & Watkins represented a group of nine international and US-based banks, who agreed...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Genuity Science, Inc. on the deal. Genomics data, analytics and insights company Genuity Science, Inc. announced its sale to HiberCell, a clinical stage biotechnology...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Ascend Wellness Holdings on the deal. Ascend Wellness Holdings, Inc. (AWH) (CSE: AAWH.U, OTCQX: AAWH), a leading multi-state, vertically integrated cannabis operator, closed a...
You must be a Standard 1 Year member to access this content.
Foley Hoag represented GreenLight., while Latham & Watkins represented Environmental Impact Acquisition Corp. in the transaction. GreenLight Biosciences, Inc., a biotechnology company dedicated to making ribonucleic acid...
You must be a Standard 1 Year member to access this content.
Kilpatrick Townsend & Stockton LLP served as legal advisor to Labcorp. Raymond James & Associates, Inc. served as exclusive financial advisor and Foley Hoag LLP served...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Alcyone Therapeutics on the deal. Alcyone Therapeutics, a Lowell, Massachusetts-based biotechnology company pioneering next-generation precision central nervous system (CNS) therapies, closed $23 million in...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Form Health on the deal. Form Health, a telemedical weight loss company, announced its $12 million Series A funding led by M13, with...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised HiFiBiO Therapeutics on the deal. FibroGen, Inc. (Nasdaq: FGEN) and HiFiBiO Therapeutics, a private, multinational clinical-stage biotherapeutics company with expertise in immune...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP advised Orlando Health on the deal. Orlando Health announced the renewal of its long-term presenting sponsorship agreement with Major League Soccer’s Orlando City...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Kula Bio on the deal. Kula Bio, a leader in sustainable nitrogen solutions, closed a $10 million seed round led by Collaborative...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc., the organism company, closed a collaboration and license agreement with Biogen (Nasdaq: BIIB) to...
You must be a Standard 1 Year member to access this content.
